by Jessica Barnes, the Indiana Horse Racing Commission

Indianapolis, IN — The Indiana Horse Racing Commission has released its staff report on the audit of its former primary laboratory, Truesdail Laboratory (Tustin, Calif.).

Findings include a total of seven missed positive tests over the 26 days in which audit testing was conducted, one of which is for a Class 1 drug–Methylphenidate (Ritalin).

The Commission terminated Truesdail Laboratory in May for its failure to meet agreed upon performance metrics. At that time, three missed positives, all for corticosteroids, were found by the audit and referee laboratories.

“We have learned a valuable lesson. Moving forward a vigorous Quality Assurance Program will become a cornerstone of our drug testing program,” said Joe Gorajec, Executive Director.

Industrial Laboratory (Denver, Colo.) has been retained as Indiana’s primary laboratory.

The Indiana Horse Racing Commission will review the report at its regularly scheduled public meeting on July 15 in Indianapolis.

The Staff Report on the audit results can be found at www.in.gov/hrc.